Page 36 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; ... Novavax, Inc.February 26, 2021 GMT Agreement includes COVID-19 vaccine technology transfer to Takeda for local manufacturing and commercialization in Japan Takeda doses first participant in immunogenicity and safety study to support local regulatory application GAITHERSBURG, Md., Feb. 26, 2021 (GLOBE ...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Peter Lougheed Centre Joins the Phase II Trial of LSALT Peptide for the Treatment of ... Arch BiopartnersFebruary 26, 2021 GMT TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the Peter Lougheed Center (PLC) in Calgary, Alberta has joined the Phase II trial of its lead drug LSALT peptide (Metab...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Amarin Corporation plcFebruary 25, 2021 GMT Record Revenue of $614.1 Million and $167.3 Million for Full Year and Fourth Quarter 2020 Despite COVID-19 Impact Received Positive CHMP Opinion for VAZKEPA ® in Europe and Continue to Advance Commercial Launch Plans for Europe Management to Host Conference Call...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent ... SpringWorks Therapeutics, Inc.February 25, 2021 GMT - Reported Interim Data from Phase 2b ReNeu Trial of Mirdametinib in NF1-PN Demonstrating Encouraging Clinical Activity and Tolerability in the First 20 Adult Patients Enrolled - -  - Continued to Strengthen Nirogacestat Patent Portfolio - - Multipl...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in ... Celsion CORPFebruary 25, 2021 GMT Of 27 patients who completed interval debulking surgery, 80% of those treated with GEN-1 had an R0 resection compared with 58% of control patients, a 38% improvement To date 34 patients, or approximately one-third of the total, have been enrolled at 22 sites, including 20 pati...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Valneva Reports FY 2020 Results and Major Corporate Achievements VALNEVAFebruary 25, 2021 GMT Excellent progress on clinical programs Unprecedented partnering deal signed with Pfizer for Lyme disease vaccine candidate VLA15, including $130 million upfront payment as part of over $300 million for upfront and milestone payments Positive initial Phase 2 results Acceleration of pediatric development ann...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from PR Newswire. The AP news staff was not involved in its creation. Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-β Agonist ASC41 February 21, 2021 GMT SHANGHAI, Feb. 21, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of nonalcoholic steatohepatitis (NASH), announces the positive clinical results in overweight an...

MEXICO CITY — Mexico says it will get its first shipment of the Chinese Coronavac vaccine Saturday and by Monday will receive its first lot of the Russian Sputnik V